Anti-infective

Study reveals ways to fight antibiotic resistance

Study reveals ways to fight antibiotic resistance

By

The solution: talk to patients.

FDA limits antibiotic use

The regulator tells farmers to limit antibiotic use.

Cubist buying spree bolsters antibiotic roster

By

The drug maker added biotechs Optimer and Trius to the fold, a bid to dominate in hard-to-treat infections.

Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman

inVentiv adds new comms exec; Julie Bowen teams up with Mylan for allergy emergencies; Royalty raises the bid on Elan; Pfizer nixes non-Hodgkin's lymphoma drug in trials.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.